Image source: Flickr user Banalities.
Continue Reading Below
Stericycle's top line continued to benefit from its recent acquisition of Shred-it. Unfortunately, the same can't be said for its bottom line, which was lower year over year because of weaker margins. That's partially because the company isn't integrating Shred-it quite as fast as expected, which is leading it to lower full-year guidance just a bit.
Stericycle results: The raw numbers
Data source: Stericycle.
What happened with Stericycle this quarter?Acquisitions continued to be the story at Stericycle.
- Stericycle's revenue increased by $210.90 million in the first quarter due primarily to the contributions of acquisitions, which alone added $194.5 million to the company's top line. That revenue growth would have been even stronger if it wasn't for the continued headwinds from the strong dollar, which led to a $23.8 million negative impact to revenue. Without the impact from foreign currency fluctuations, revenue would have increased by 35.4%.
- Earnings roughly followed revenue higher on an absolute basis, with non-GAAP gross profit also soaring more than 31%. However, on a per share basis, earnings slipped 3.5%.
- That was partially due to weaker margins, with Stericycle's income from operations as a percentage of revenue slipping from 24.4% to 20.6% because of an increase in sales, general, and administrative (SG&A) expenses.
What management had to sayCEO Charlie Alutto led off the company's conference call discussing the results by saying:
As Alutto notes, the Shred-it acquisition drove strong revenue growth during the quarter. However, earnings growth was muted due to the timing of the expected synergies from that transaction, which was evidenced by the higher SG&A costs. COO Brent Arnold pinpointed the problem on the call, noting that the company has "reassessed the original timeline associated with the reroutes and onsite-to-offsite conversions." He also said the company still remains "confident in our ability to achieve the full $73 million in Cintas -Shred-It synergies."
Looking forwardGiven the slower-than-expected synergy capture, Alluto provided an update to the company's guidance for 2016:
That's a bit weaker than the prior guidance, which called for revenue growing to a range of $3.65 billion to $3.72 billion, with non-GAAP earnings growing to a range of $5.28 to $5.35 per share.
The article Slow Synergy Capture "Shreds" Stericycle Inc's Earnings Growth originally appeared on Fool.com.
Matt DiLallo owns shares of Stericycle. The Motley Fool recommends Cintas and Stericycle. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright 1995 - 2016 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.